IMA FY 2020 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-33.1% YoY

Gross Profit

-$36M-387.8% margin

Operating Income

-$45M-484.2% margin

Net Income

-$44M-481.4% margin

EPS (Diluted)

$-3.16

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$39M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$168M

Total Liabilities

$269M

Stockholders' Equity

-$101M

Cash & Equivalents

$162M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$14M	-33.1%
Gross Profit	-$36M	-$11M	-218.8%
Operating Income	-$45M	-$18M	-140.7%
Net Income	-$44M	-$17M	-163.2%